+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

From
Oncologists Market Report 2025 - Product Thumbnail Image

Oncologists Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • July 2025
  • 184 Pages
  • Global
From
Glomerulonephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Glomerulonephritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Focal Segmental Glomerulosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Investor Series: Opportunities in RNA Therapeutics Market - Product Thumbnail Image

Investor Series: Opportunities in RNA Therapeutics Market

  • Report
  • March 2023
  • 174 Pages
  • Global
From
From
From
From
Pharmaceutical Excipients Market Report 2025 - Product Thumbnail Image

Pharmaceutical Excipients Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
Geographic Atrophy (GA)- Pipeline Insight, 2025 - Product Thumbnail Image

Geographic Atrophy (GA)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Orphan Drugs Market Report 2023-2033 - Product Thumbnail Image

Orphan Drugs Market Report 2023-2033

  • Report
  • October 2023
  • 258 Pages
  • Global
From
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 182 Pages
  • Global
From
From
From
From
Loading Indicator